Portfolio Lab

IBEX Ltd

  • Stock
  • Ticker IBEX
  • ISIN BMG4690M1010
  • Nasdaq
  • US listing in dollars

Technology · Software and IT services · USA

$54.01 +0.04%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of IBEX Ltd since 08/2020, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

IBEXGlobal equities (VT)

$10,000 grew to $33,237. Global equities (VT): $14,653.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −56.0% in 04/2024, measured from the peak in 02/2023. It took 27 months to get back to the old peak.

1-year return
+59.3%
5-year return p.a.
+25.0%
Return p.a. since 08/2020
+22.1%
Volatility p.a.
40.4%
Largest decline
−56.0%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue141141147151164164164175
Operating income1213121415169.818
EBITDA1618171820211523
Net income9.3109.61212138.715
Earnings per share0.570.730.660.820.830.890.590.99
Balance sheet
Total assets272275273284296297309333
Liabilities164151139140141136139151
Equity109124134144155161170182
Cash2013152315153337
Cash flow
Operating cash flow1.18.828166.6122516
Capital expenditure-4.3-5.3-5.2-7.6-12-5.3-3.2-7.2
Free cash flow-3.23.6238.0-5.16.6229.2

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2022 at +92.8%, weakest 2021 at −31.1%. 3 of 5 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$0.99
10 Sep 2026$0.59
6 May 2026$0.89
5 Feb 2026$0.83
6 Nov 2025$0.82
11 Sep 2025$0.66
8 May 2025$0.73
6 Feb 2025$0.57
7 Nov 2024$0.43
12 Sep 2024$0.55
9 May 2024$0.57
8 Feb 2024$0.33

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€653m
Market cap in trading currency
$720m
Enterprise value
$684m
P/E
16.4
P/S
1.08
P/B
3.97
EV/Sales
1.02
EV/EBITDA
8.6
Earnings yield
6.1%
FCF yield
4.5%

Results (last four quarters)

Revenue
$668m
Gross profit
–
EBITDA
$80.0m
Net income
$49.1m
Earnings per share
$3.30
Revenue per share
$50.11
Revenue growth
+15.9%
Earnings growth
+22.7%

Profitability

Gross margin
–
Operating margin
8.9%
Net margin
7.3%
Return on equity
30.2%
Return on assets
14.8%

Balance sheet and cash flow

Cash
$36.7m
Cash per share
$2.75
Financial debt
$872,000
Debt/equity %
0
Current ratio
2.03
Book value per share
$13.62
Operating cash flow
$59.7m
Free cash flow
$32.3m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
13.3m
Volume
102,283
Avg. volume 3 months
132,970
Relative volume
0.7

Price and technicals

Price
$54.01
1 day
0.0%
52-week high
$56.92
52-week low
$26.40
Distance to 52-week high
−5.1%
Distance to 52-week low
+104.6%
Distance to 50-day line
+16.8%
Distance to 200-day line
+53.1%
RSI (14)
65
Volatility 1M
60.8%

Performance

1 week
−5.1%
1 month
+15.1%
3 months
+46.6%
6 months
+68.7%
YTD
+41.5%
1 year
+54.8%

Dates

Fiscal year end
30 Jun 2026
Most recent quarter
30 Sep 2026

Frequently asked questions

How has IBEX performed since 08/2020?

$10,000 grew to $35,071 by 20 Nov 2026, which is +22.1% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is IBEX?

Volatility was 40.4% per year, measured on monthly returns. The largest decline from a peak was −56.0%, with the low in 04/2024.

How does IBEX compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.6% per year at 15.1% volatility, IBEX returned +22.1% at 40.4%. The correlation of monthly returns was 0.29; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Why does this page show a US listing?

The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

IBEX Ltd (IBEX): Return and risk | Portfolio Lab